Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease

Journal of Clinical Microbiology

Volumn 33, Issue 8, 1995, Pages 2086-2090

  Krautz, G M ^a   Galvao, L M C ^a   Cancado, J R ^a   Guevara Espinoza, A ^a   Ouaissi, A ^a   Krettli, A U ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; CHAGAS DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0029047960     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.33.8.2086-2090.1995     Document Type: Article

References (0)